Mavlyanova NN^1*

¹Republican specialized scientific and practical medical center of obstetrics and gynecology under the Ministry of Health of the Republic of Uzbekistan, Uzbekistan.

*Corresponding Author: Mavlyanova NN, Republican specialized scientific and practical medical center of obstetrics and gynecology under the Ministry of Health of the Republic of Uzbekistan, Uzbekistan, Tel: + (998 71) 205 14 14; Fax: + (998 71) 237 22 72; E-mail: nigora-m@yandex.com

Citation: Mavlyanova NN(2022) Molecular Research of Polymorphism (Rs1695) Iie 105 Val Gene FGB in Pregnant Women with Fetal Loss Syndrome in Uzbekistan.Arch Mol Med & Gen 4:112.

Copyright: © 2022 Mavlyanova NN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: June 20, 2022; Accepted: July 06, 2022; Published: July 09, 2022

Pregnancy; Fetoplacental Insufficiency; Fetal Loss Syndrome; Genetics; "Circulatory System" of the Gene.
With the development of a genetic approach to the study of the etiology and pathogenesis of many diseases, including FPI, great importance has been attached to congenital or hereditary disorders in the processes of storage, transmission and realization of genetic information. In a view of the priority of endothelial dysfunction in the FPI genesis, the importance of the vascular system, as the main diagnostic feature of the disease, and findings of previous studies on the genetics of this pathology, namely the existence of polymorphism of the "vascular system" and "endothelial dysfunction" genes in many ways can explain the obvious individual differences in origin and course of the disease.
The aim of our research was to determine the frequency of polymorphisms of hemostasis and fibrinolysis genes: FGB in pregnant women in Uzbekistan.

The object and subject of the study were pregnant women, patients' DNA samples and the FGB gene (rs1695) IIe 105 Val fibrinolysis gene. The study included 50 pregnant women aged from 20 to 45 years who were observed at the base of the clinic of the RSSPMC for Obstetrics and Gynecology under the Ministry of Health of the Republic of Uzbekistan [1]. All the pregnant women have underwent clinical, laboratory, instrumental and functional (ultrasound) studies. The FPI was diagnosed on the basis of clinical, laboratory and functional studies [2-4]. Molecular genetic examination of biomaterials (DNA) was performed on the Department of Molecular Medicine and Cellular Technologies of the Research Institute of Hematology and Blood Transfusion under the Ministry of Health of the Republic of Uzbekistan.
DNA samples were isolated from peripheral blood lymphocytes in accordance with the modified method. The concentration and purity of the isolated DNA was assessed by measuring the optical density of DNA-containing solutions at a wavelength of 260 and 280 nm against TE on a Nano Drop 2000 spectrophotometer (USA) [5]. PAI polymorphism genotype was determined by PCR on programmable thermal cyclers CG-1-96 Corbett Research (Australia) and 2720 Applied Biosystems (USA) using test systems of Liteh LLC (Russia), according to the manufacturer's instructions. The temprature mode was set as follows: 94°C - 4 minutes; 94°C- 30 seconds, 60°C -30 seconds, 72°C - 30 – 35 cycle; 72°C - 7 minutes.
statistical analysis of the results was carried out using the statistical software package "OpenEpi 2009, Version 2.3". The frequency of variants of alleles and genotypes (f) was calculated by the formula: f=n/2N ? f=n/N, where n is the incidence of the variant (allele and genotype) and N is sample size [6-8].

The results of clinical, instrumental and functional studies of 50 pregnant women showed that fetoplacental insufficiency(FPI) was diagnosed in 40, which accounted for 80% of cases. Information about gene sequences and primer structure was obtained taking into account the original literary source and in Gene Bank [9]. We have studied the distribution of polymorphisms of the IIe 105Val enzyme gene FGB in pregnant women with FPI and the control group without FPI. (Table 1).
Table 1: The frequency distribution of alleles and genotypes of IIe 105 Val polymorphism of the FGB gene in groups of pregnant women with FLS and controls (without FLS).

n –the number of patients examined; * n - the number of alleles studied

As can be seen from the table, a comparative analysis of the distribution frequencies of alleles and genotypes of the FGB fibrinolysis gene IIe 105 Val polymorphism among 80 DNA samples in 40 pregnant women revealed the presence of a normal A allele and the G allele in 87.5% and in 12.5% of cases, respectively. (χ²=0.1; ?=0.8; OR=1.2; 95%CI 0.306-4.983)
Whereas, in the control group in 10 pregnant women without FPI, the frequency of incidence of the normal allele A of the FGB gene was 85%, whereas the FGB gene IIe 105 Val mutant A allele was 15%, respectively [10]. The frequency distribution of the genotypes of this polymorphism also revealed significant differences between the main and control comparison groups in the total sample. (?<0.05).
Thus, A/A genotypes were observed in 30 pregnant women with FPI, which accounted for 75% of cases. Whereas, the A/G genotypes of the FGB gene was found in 10 out of 40 pregnant women with FPI, which amounted to 25.0%, and in the group of pregnant women without FPI it was found in 1 women (10.0%), respectively [11-13]. The G / G genotype was found in 1 (10.0%) pregnant women without FPI. According to the odds ratio, the risk of developing FPI in the main group in the presence of G / A polymorphism (χ²=1.0; ?=0.3; OR=3.0; 95%CI 0.3- 26.71) is 2.5 times higher compared to the control group of pregnant women without FPI.

Table 2: Expected and observed frequencies of distribution of genotypes of IIe FGB gene 105Val polymorphism by RCM in the group of pregnant women with FLS.

As follows from table 2, indicators of the frequency of the distribution of genotypes according to the RCM of FGB gene IIe 105 Val polymorphism in the main group of pregnant women with FPI showed that the observed frequency of A / A genotypes was found in 75.0%, heterozygous A/G genotypes in 25.0% and homozygous - G/G genotypes in 0%, respectively, whereas the expected frequency of A / A and heterozygous A / G genotypes in the group were found in 76.6% and 21.8% of cases, respectively, and G/G - in 1.56%. For the IIe 105Val FGB gene in the group of pregnant women with FWS, the empirical (H_obs) distribution of genotypes corresponds to the theoretically expected (H_exp) in PSC (p>0.05) [14].

Table 3: Expected and observed frequencies of distribution of FGB gene IIe 105Val polymorphism genotypes by RCM in the group of pregnant women without FWS.

While in the control group of pregnant women without FPI, the observed frequency of A / A genotypes was found in 80% of cases, and the expected frequency of genotypes was 72.3%, whereas the frequency of heterozygous A / G genotypes was found in 10% and 25.5% of cases , and homozygous mutant genotypes G / G were determined in 10 and 2.6%, respectively. (table 3). For this locus, the empirical (H_obs) distribution of genotypes in the control group almost corresponds to the theoretically expected (H_exp) in RCM (p> 0.05) [15]. However, there is a tendency to deviate.
Thus, the results of the study showed a tendency to increase of the expected mutant in the main group of pregnant women with placental insufficiency (FPI) against the group without FPI (10% and 2.25% respectively.). The results require further study of this gene in pregnant women.

1. Aulchenko YuS, Aksenovich TP (2006) Methodological approaches and strategies for mapping genes controlling complex human traits. Bulletin of VOGiS. 10: 189-202.
2. Demin GS (2007) Genetic aspects of predisposition to gestosis / G.S. Demin. Journal of Obstetrics and Women's Diseases 4: 74-86.
3. Karimov KhYa, Saidov AB, Boboev KT, Assesorova YuYu, et al. (2016) Fundamental and applied aspects of molecular genetics in medicine. / Scientific publication. - Tashkent: IPTD "Uzbekistan",  p. 352
4. Lyubchich NI (2016) Pathogenetic aspects of preterm labor in thrombophilia (principles of diagnosis and prevention). // Thesis of doc. diss. - Tashkent. p. 76.
5. Baranov VS (2000) The human genome and the genes of "predisposition". Introduction to predictive medicine / V. S. Baranov, E. V. Baranova, T. E. Ivaschenko, M. V. Aseev - SPb: Intermedica, p. 271.
6. Baranov VS, Aylamazyan EK (2007) Ecological and genetic causes of reproductive health disorders and their prevention. Journal of Obstetrics and Women's Diseases LVI: 3-10.
7. Bespalova ON (2007) Genetics of miscarriage. Journal of Obstetrics and Women's Diseases LVI: 81-95.
8. Karimov KhYa, Saidov AB, Boboev KT, Assesorova YuYu, et al. (2016) Fundamental and applied aspects of molecular genetics in medicine. / Scientific publication. - Tashkent: IPTD "Uzbekistan", p. 352.
9. Bots ML, Elwood PC, Salonen JT, Freire de Concalves A, Sivenius J, et al. (2002) Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 56: i14-18.
10. Faisel F, Romppanen EL, Hiltunen M, et al. (2004) Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation. Eur J Hum Genet 12: 187-191.
11. Lee SH, Kim MK, Park MS, Choi SM, Kim JT, et al. (2008) beta-Fibrinogen Gene -455 G/A Polymorphism in Korean Ischemic Stroke Patients. J Clin Neurol. 4: 17-22.
12. Martiskainen M, Pohjasvaara T, Mikkelsson J, Mäntylä R, Kunnas T, et al. (2003) Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke. Stroke 34: 886-8891.
13. Mavlyanova NN, Ixtiyarova GP, Tosheva II, Aslonova M, Narzullaeva NS, et al. The state of the cytokine in pregnanat women with fetal growth retardation. Journal of Medical –Clinical Research and Reviews 4: 4.
14. Oszajca K, Wronski K, Janiszewska G, Bienkiewicz M, Panek M, et al. (2012) Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen? chain genes with human abdominal aortic aneurysm. Exp Ther Med. 4: 514-518.
15. Ticconi C, Mancinelli F, Gravina P, Federici G, Piccione E, et al. (2011) Beta-fibrinogen G-455A polymorphisms and recurrent miscarriage. Gynecol Obstet Invest. 71: 198-201.